Hydrochlorothiazide Capsule
Product Images NDC 57237-002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 57237-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (12.5 mg (100 Capsule Bottle))

Package Label-principal Display Panel (12.5 mg (100 Capsule Bottle))
Rising noc 57237-002-01 is a medication in capsule form containing Hydrochlorothiazide USP 12.5 mg. The medication should be stored at 20° to 25°C (68° to 77°F) and dispensed in a tight light-resistant container as defined in the USP. It is recommended to keep the medication away from children and protect from light, moisture, and freezing. The package includes information on usual dosage and administration. Rising noc 57237-002-01 is distributed by Rising Health, LLC and manufactured in India. The code listed is TS/DRUGS/19/1993, and the most recent revision was made in January 2018.*
FDA Label Image

Chemical Structure (Hydrochloro Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.